Ganglionic Activity of Cardiovascular Drugs
Since the major use of ganglion-blocking drugs is in the treatment of cardiovascular disease, it is necessary to discuss the interaction between these blocking drugs and cardiovascular drugs. This section will examine three form of pharmacological actions and interactions: first, the effect of cardiovascular drugs on the autonomic ganglia; second, the influence of ganglionic blockade on the haemodynamic action of cardiovascular drugs; and third, the influence of cardiovascular drugs on the hypotensive action of ganglion-blocking drugs.
KeywordsAdrenal Medulla Sympathetic Ganglion Cardiovascular Drug Superior Cervical Ganglion Tyrosine Hydroxylase Activity
Unable to display preview. Download preview PDF.
- Aviado, D.M.: Norepinephrine. In: Sympathomimetic drugs. Springfield: Thomas 1970Google Scholar
- Trendelenburg, U.: Some aspects of the pharmacology of autonomic ganglion cells. In: Reviews of physiology, biochemistry, and experimental pharmacology, Vol. 59. Berlin, Heidelberg, New York: Springer 1967Google Scholar